Literature DB >> 24147730

Health-related quality of life and functional outcome in cardiac surgical patients aged 80 years and older: a prospective single center study.

Marcus-André Deutsch1, Markus Krane, Lisa Schneider, Michael Wottke, Matthias Kornek, Yacine Elhmidi, Catalin Constantin Badiu, Sabine Bleiziffer, Bernhard Voss, Rüdiger Lange.   

Abstract

BACKGROUND: An increasing number of octogenarians are referred for cardiac surgical procedures. In this subset of patients, information on the health-related quality of life (HrQoL) is critical for decision making. However, there is a paucity of prospective data. Thus, we sought to prospectively evaluate the HrQoL in octogenarians undergoing cardiac surgery.
METHODS: A prospective HrQoL analysis was performed in 106 elective patients (median age 83.0 ± 2.6 years, range 80-91.8 years, 59.4% male) undergoing cardiac surgery. The standardized SF-36 Health Survey questionnaire was answered preoperatively, and three and 12 months postoperatively. Preoperative data, perioperative outcome, and postoperative morbidity were analyzed.
RESULTS: SF-36 scores for physical functioning (44.3 ± 2.3 vs. 52.0 ± 2.7; p < 0.001), role physical (25.2 ± 3.3 vs. 41.5 ± 4.1; p < 0.001), bodily pain (57.8 ± 3.2 vs. 70.7 ± 2.8; p < 0.01), general health (54.9 ± 1.7 vs. 59.6 ± 1.7; p < 0.001), vitality (41.1 ± 2.1 vs. 50.6 ± 2.1; p < 0.001), and mental health (67.5 ± 2.0 vs. 72.4 ± 1.9; p < 0.05) significantly improved from baseline to three months. Social functioning (75.4 ± 2.6 vs. 76.1 ± 2.5; p = 0.79) and role emotional (56.8 ± 4.5 vs. 58.0 ± 4.6; p = 0.29) improved slightly without reaching statistical significance. Correspondingly, at three months, physical component scores increased significantly compared to baseline (34.3 ± 1.0 vs. 39.4 ± 1.0; p < 0.001). SF-36 scores remained stable between three months and one year. No significant change was seen in the mental component score from baseline to three months (48.6 ± 1.2 vs. 49.8 ± 1.1; p = 0.18).
CONCLUSIONS: Physical HrQoL is significantly improved in octogenarians three months after cardiac surgery remaining stable at one year postoperatively when compared to baseline.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24147730     DOI: 10.1111/jocs.12233

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  4 in total

1.  Quality of life 10 years after cardiac surgery in adults: a long-term follow-up study.

Authors:  Andrea Perrotti; Fiona Ecarnot; Francesco Monaco; Enrica Dorigo; Palmiero Monteleone; Guillaume Besch; Sidney Chocron
Journal:  Health Qual Life Outcomes       Date:  2019-05-22       Impact factor: 3.186

2.  Minimally invasive versus conventional sternotomy for Mitral valve repair: protocol for a multicentre randomised controlled trial (UK Mini Mitral).

Authors:  Rebecca H Maier; Adetayo S Kasim; Joseph Zacharias; Luke Vale; Richard Graham; Antony Walker; Grzegorz Laskawski; Ranjit Deshpande; Andrew Goodwin; Simon Kendall; Gavin J Murphy; Vipin Zamvar; Renzo Pessotto; Clinton Lloyd; Malcolm Dalrymple-Hay; Roberto Casula; Hunaid A Vohra; Franco Ciulli; Massimo Caputo; Serban Stoica; Max Baghai; Gunaratnam Niranjan; Prakash P Punjabi; Olaf Wendler; Leanne Marsay; Cristina Fernandez-Garcia; Paul Modi; Bilal H Kirmani; Mark D Pullan; Andrew D Muir; Dimitrios Pousios; Helen C Hancock; Enoch Akowuah
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

3.  Depressive symptoms, perceived control and quality of life among patients undergoing coronary artery bypass graft: a prospective cohort study.

Authors:  Mohannad Eid AbuRuz; Ghadeer Al-Dweik
Journal:  BMC Nurs       Date:  2022-04-12

4.  Preoperative determinants of quality of life a year after coronary artery bypass grafting: a historical cohort study.

Authors:  Lisa Verwijmeren; Peter Gerben Noordzij; Edgar Jozeph Daeter; Bas van Zaane; Linda Margaretha Peelen; Eric Paulus Adrianus van Dongen
Journal:  J Cardiothorac Surg       Date:  2018-11-19       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.